Literature DB >> 8253797

Transcriptional enhancer factor-1 in cardiac myocytes interacts with an alpha 1-adrenergic- and beta-protein kinase C-inducible element in the rat beta-myosin heavy chain promoter.

K Kariya1, I K Farrance, P C Simpson.   

Abstract

In cultured rat cardiac myocytes, a 20-base pair sequence (-215/-196) of the rat beta-myosin heavy chain (MHC) promoter mediates induction by both alpha 1-adrenergic stimulation and a constitutively activated beta-protein kinase C (PKC), and binds cardiac myocyte nuclear factor(s) through an "enhancer core" element (5'-TGTGG-TATG-3') (Kariya, K., Karns, L. R., and Simpson, P. C. (1994) J. Biol. Chem. 269, in press). Here, we report identification of this enhancer core binding factor as the rat homologue of transcriptional enhancer factor-1 (TEF-1), a human transcription factor for viral enhancers. In gel mobility shift and immunoblot analyses, the myocyte factor and human TEF-1 were indistinguishable in terms of sequence recognition, mobility, and immunoreactivity. Furthermore, DNA binding activity for the beta-MHC enhancer core and TEF-1 immunoreactivity correlated closely. These results are the first to suggest a role for TEF-1 in transcriptional regulation by PKC. The data also provide direct evidence for interaction of TEF-1 with the beta-MHC promoter, supporting a function for TEF-1 in regulation of cellular gene expression, as well as viral, and outline a pathway for alpha 1-adrenergic regulation of beta-MHC gene transcription in cardiac myocytes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8253797

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Identification of a cis-acting regulatory element conferring inducibility of the atrial natriuretic factor gene in acute pressure overload.

Authors:  R von Harsdorf; J G Edwards; Y T Shen; R K Kudej; R Dietz; L A Leinwand; B Nadal-Ginard; S F Vatner
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 2.  Re-employment of developmental transcription factors in adult heart disease.

Authors:  Toru Oka; Jian Xu; Jeffery D Molkentin
Journal:  Semin Cell Dev Biol       Date:  2006-11-24       Impact factor: 7.727

3.  A novel E box/AT-rich element is required for muscle-specific expression of the sarcoplasmic reticulum Ca2+-ATPase (SERCA2) gene.

Authors:  D L Baker; V Dave; T Reed; S Misra; M Periasamy
Journal:  Nucleic Acids Res       Date:  1998-02-15       Impact factor: 16.971

4.  Chromatin remodelling of the cardiac beta-myosin heavy chain gene.

Authors:  W Y Huang; C C Liew
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

5.  Flanking sequences modulate the cell specificity of M-CAT elements.

Authors:  S B Larkin; I K Farrance; C P Ordahl
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

Review 6.  The role of interleukin-1 in the failing heart.

Authors:  C S Long
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

7.  The Kruppel-like transcription factor KLF13 is a novel regulator of heart development.

Authors:  Geneviève Lavallée; Gregor Andelfinger; Mathieu Nadeau; Chantal Lefebvre; Georges Nemer; Marko E Horb; Mona Nemer
Journal:  EMBO J       Date:  2006-10-19       Impact factor: 11.598

8.  An M-CAT binding factor and an RSRF-related A-rich binding factor positively regulate expression of the alpha-cardiac myosin heavy-chain gene in vivo.

Authors:  J D Molkentin; B E Markham
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

9.  Cardiac p300 is involved in myocyte growth with decompensated heart failure.

Authors:  Tetsuhiko Yanazume; Koji Hasegawa; Tatsuya Morimoto; Teruhisa Kawamura; Hiromichi Wada; Akira Matsumori; Yosuke Kawase; Maretoshi Hirai; Toru Kita
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

Review 10.  Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance.

Authors:  Timothy D O'Connell; Brian C Jensen; Anthony J Baker; Paul C Simpson
Journal:  Pharmacol Rev       Date:  2013-12-24       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.